We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · May 05, 2020

Metabolic Tumor Volume After 3 Months of ICI Therapy Is Prognostic of Survival in Melanoma Patients

European journal of nuclear medicine and molecular imaging

 

Additional Info

European journal of nuclear medicine and molecular imaging
Prognostic Value of Volumetric PET Parameters at Early Response Evaluation in Melanoma Patients Treated With Immunotherapy
Eur. J. Nucl. Med. Mol. Imaging 2020 Apr 15;[EPub Ahead of Print], R Nakamoto, LC Zaba, J Rosenberg, SA Reddy, TW Nobashi, G Davidzon, CM Aparici, J Nguyen, F Moradi, A Iagaru, BL Franc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading